Clinical Outcomes of Primary Bladder Carcinoma In Situ in a Contemporary Series

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 74-80

  Chade, Daher C ^a   Shariat, Shahrokh F ^a   Godoy, Guilherme ^a   Savage, Caroline J ^a   Cronin, Angel M ^a   Bochner, Bernard H ^a   Donat, S Machele ^a   Herr, Harry W ^a   Dalbagni, Guido ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BCG vaccine; carcinoma in situ; urinary bladder neoplasms

Indexed keywords

BCG VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER CARCINOMA IN SITU; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CARCINOMA IN SITU; CONTROLLED STUDY; COURSE EVALUATION; CYSTECTOMY; FEMALE; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICTURITION DISORDER; OUTCOME ASSESSMENT; PRIMARY TUMOR; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING HABIT; TRANSURETHRAL RESECTION; TREATMENT RESPONSE;

AGED; BCG VACCINE; CARCINOMA IN SITU; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77953120399     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.032     Document Type: Article

References (19)

1. Sylvester R.J., van derMeijden A., Witjes J.A., et al. High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 66 (2005) 90
2. van Rhijn B.W., Burger M., Lotan Y., et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 56 (2009) 430
3. Lamm D., Herr H., Jakse G., et al. Updated concepts and treatment of carcinoma in situ. Urol Oncol 4 (1998) 130
4. Nese N., Gupta R., Bui M.H., et al. Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis. J Natl Compr Canc Netw 7 (2009) 48
5. Andius P., Damm O., and Holmang S. Prognostic factors in patients with carcinoma in situ treated with intravesical bacille Calmette-Guerin. Scand J Urol Nephrol 38 (2004) 285
6. Gofrit O.N., Pode D., Pizov G., et al. The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Guerin immunotherapy. Urol Oncol 27 (2009) 258
7. Sylvester R.J. Natural history, recurrence, and progression in superficial bladder cancer. ScientificWorldJournal 6 (2006) 2617
8. Hall M.C., Chang S.S., Dalbagni G., et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178 (2007) 2314
9. Althausen A.F., Prout Jr. G.R., and Daly J.J. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116 (1976) 575
10. Lamm D.L. Carcinoma in situ. Urol Clin North Am 19 (1992) 499
11. Sylvester R.J., van derMeijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 (2006) 466
12. Farrow G.M., Utz D.C., Rife C.C., et al. Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res 37 (1977) 2794
13. Utz D.C., and Farrow G.M. Carcinoma in situ of the urinary tract. Urol Clin North Am 11 (1984) 735
14. Utz D.C., Farrow G.M., Rife C.C., et al. Carcinoma in situ of the bladder. Cancer 45 (1980) 1842
15. Farrow G.M., Utz D.C., and Rife C.C. Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res 36 (1976) 2495
16. Herr H.W., and Dalbagni G. Defining bacillus Calmette-Guerin refractory superficial bladder tumors. J Urol 169 (2003) 1706
17. Denzinger S., Fritsche H.M., Otto W., et al. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?. Eur Urol 53 (2008) 146
18. Herr H.W., and Sogani P.C. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. J Urol 166 (2001) 1296
19. Herr H.W. Age and outcome of superficial bladder cancer treated with bacille Calmette-Guerin therapy. Urology 70 (2007) 65